INTELLIA THERAPEUTICS, INC. (NTLA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading NTLA…

INTELLIA THERAPEUTICS, INC. (NTLA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

INTELLIA THERAPEUTICS, INC.

NTLA · CIK 1652130

4 · Oct 6, 2026 · VP, Chief Accounting Officer Dube Michael P sold 1,864 shares at $12.43/share ($23,170)

4

VP, Chief Accounting Officer Dube Michael P sold 1,864 shares at $12.43/share ($23,170)

Filed: Oct 6, 2026
Period: Oct 2, 2026
Accession: 0001193125-26-415541
Filer: Intellia Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov